Hypocalcemia in Piglets Reduces Cardiac and Pulmonary Vascular Disturbance after Hypoxemia and Reoxygenation during Cardiopulmonary Bypass

Abstract BACKGROUND: Placing cyanotic newborns on cardiopulmonary bypass (CPB) and performing abrupt reoxygenation affects myocardial Performance. This study tests the hypothesis that hypocalcemia is benefical in this circumstance of reoxygenation. METHODS: Twenty-one newborn piglets (anesthetized,...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Thoracic and cardiovascular surgeon 1999-10, Vol.47 (5), p.302-310
Hauptverfasser: Baretti, R., Mizuno, A., Buckberg, G. D., Young, H. H.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Abstract BACKGROUND: Placing cyanotic newborns on cardiopulmonary bypass (CPB) and performing abrupt reoxygenation affects myocardial Performance. This study tests the hypothesis that hypocalcemia is benefical in this circumstance of reoxygenation. METHODS: Twenty-one newborn piglets (anesthetized, openchests) were placed for one hour on CPB. Seven piglets under normoxic and normocalcemic conditions were the controls. The other piglets underwent hypoxemia and subsequent reoxygenation, for periods of 30 minutes each, under normo-calcemic (Normo-Ca ++ , n = 7) or hypocalcemic conditions (Hypo-Ca ++ , n = 7). Thirty minutes after discontinuation of CPB, the hemodynamic function was assessed taking into account stroke work indices (SWI), end systolic elastance (EES), pulmonary vascular resistance index (PVRI), cardiac release of conjugated dienes (CD) and creatine phosphokinase (CK), and myocardial oxygen consumption (MV02). These parameters were expressed as a percentage of the pre-CPB value. The endogenous antioxidant reserve capacity (AORC) of ventricular wall specimens was determined by in-vitro lipid peroxidation forming malondealdehyde (nmol MDA/g protein). RESULTS: After one hour of CPB the cardiac Performance returned to normal range without any functional or metabolic disturbance. The normocalcemic condition resulted in a hardly impaired cardiac performance (42%**SWI; 67%**EES), an augmented PVRI (more than 4-fold**), and highly elevated release of CD and CK (3-fold * * each). The Normo-Ca ++ group's MV02 (95 ±14%) was unaltered. The hypocalcemic condition improved the myocardial function to near control value (85 % SWI; 91 % EES) and attenuated the augmentation of the PVRI (n.s. vs. Control group) down to 64% of the Normo-Ca ++ group's level. The release of CD and CK in the Hypo-Ca ++ group (both n.s. vs. Control group) only minimally increased. The Hypo-Ca ++ group's MV02 improved (137±8%*). The MDA formation was worse (344±38**) in the Normo-Ca ++ group, but unaltered in the Hypo-Ca ++ group (203±9; n.s. vs. Control group (218±20)). * = p
ISSN:0171-6425
1439-1902
DOI:10.1055/s-2007-1013163